AbbVie, Inc. (ABBV)
256.30
-3.91
(-1.50%)
USD |
NYSE |
Sep 04, 15:12
AbbVie Cash and Short Term Investments (Annual) : 5.257B for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 5.257B |
| December 31, 2024 | 5.555B |
| December 31, 2023 | 12.82B |
| December 31, 2022 | 9.229B |
| December 31, 2021 | 9.83B |
| December 31, 2020 | 8.479B |
| December 31, 2019 | 39.92B |
| December 31, 2018 | 8.061B |
| Date | Value |
|---|---|
| December 31, 2017 | 9.789B |
| December 31, 2016 | 6.423B |
| December 31, 2015 | 8.407B |
| December 31, 2014 | 8.374B |
| December 31, 2013 | 9.895B |
| December 31, 2012 | 7.976B |
| December 31, 2011 | 653.58M |
| December 31, 2010 | 1.883B |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Biogen, Inc. | 3.816B |
| Gilead Sciences, Inc. | 9.613B |
| Regeneron Pharmaceuticals, Inc. | 8.611B |
| Amgen, Inc. | 9.129B |
| REGENXBIO, Inc. | 230.07M |